SYNOPSIS A very rapid method of agar gel electrophoresis on glass slides, together with a superior visualization technique employing simultaneous coupling of a hydrolysed naphthol substrate, have been developed for the identification of the tissues of origin of serum alkaline phosphatase. Combined with L-phenylalanine inhibition, specific for the intestinal enzyme, and heat inactivation, specific for the placental enzyme, the heterogeneity of serum alkaline phosphatase has been demonstrated. Normal adult serum contains predominantly liver-type alkaline phosphatase with a small but variable quantity of intestinal enzyme, and little or no bone enzyme.
SYNOPSIS A very rapid method of agar gel electrophoresis on glass slides, together with a superior visualization technique employing simultaneous coupling of a hydrolysed naphthol substrate, have been developed for the identification of the tissues of origin of serum alkaline phosphatase. Combined with L-phenylalanine inhibition, specific for the intestinal enzyme, and heat inactivation, specific for the placental enzyme, the heterogeneity of serum alkaline phosphatase has been demonstrated. Normal adult serum contains predominantly liver-type alkaline phosphatase with a small but variable quantity of intestinal enzyme, and little or no bone enzyme. In childhood and in infancy there is in addition a bone isoenzyme present, the amount gradually falling to adult levels with age. In pregnancy, the rise in serum alkaline phosphatase is due to the placental enzyme.
A study of nearly 2,000 sera has been undertaken and it is found that the bone enzyme is increased in osteoblastic bone diseases while in hepato-biliary disorders there is an increase in liver type enzyme. The main theories explaining the rise in serum alkaline phosphatase are examined.
The origin of serum alkaline phosphatase has interested many workers ever since Kay (1929) and Roberts (1930) first demonstrated that increased serum activity was found in certain bone and hepatobiliary disorders. The problem of the origin of the enzyme is intricately bound up with that of the mechanisms by which the serum activity is increased or decreased in health and in disease. It has long been realized that serum alkaline phosphatase arises from tissues rich in the enzyme (Kay, 1932) . Previous attempts at identification of the tissues of origin were handicapped not only by lack of direct methods, but also by the influence of the work of Robison and his associates linking alkaline phosphatase with calcification (Robison, 1923; Robison and Soames, 1924 ,1925 ,1930 Robison, MacLeod, and Rosenheim, 1930; Robison and Rosenheim, 1934; Martland and Fell and Robison, 1929) . The former led to theories based on indirect observations. Nearly all these theories assumed that the serum enzyme was of osseous origin.
In recent years, the realization that enzymes may exist in multiple structural forms has provided an impetus to development of techniques of separating these 'isoenzymes'. Of The alkaline phosphatase isoenzymes appeared as red bands while serum proteins were stained a very faint yellow. The positions of these isoenzymes relative to the protein fractions could thus be easily seen. After eluting as for the proteins, incubations overnight produced transparent slides.
PHENYL-ALANINE INHIBITOR 0-005M L-phenyl alanine, which specifically inhibits intestinal alkaline phosphatase (Fishman, Green, and Inglis, 1963) , was incorporated into the substrates in some instances. The D-isomer was then used as a control.
HEATING Electrophoresis was performed on sera before and after heating to 56°C. for 30 minutes in the presence of OO1M magnesium chloride . TISSUE EXTRACTS Tissue for the extraction of alkaline phosphatase were obtained at necropsies on young adults dying from road traffic accidents. They were used within 24 hours or stored at -20°C. Adult bone was too difficult to homogenize and femurs from stillborn infants were used instead. After cutting the tissues into small pieces homogenization was performed using a Potter-Elvehjem homogenizer and the enzyme extracted by the butanol method of Morton (1954 Significant advances were made when L-phenylalanine, zone electrophoresis, and heat stability were utilized. Fishman and his associates (Fishman et al., 1962 (Fishman et al., , 1963 showed that L-phenylalanine specifically inhibited intestinal alkaline phosphatase.
Paper electrophoresis of alkaline phosphatase was introduced by Baker and Pellegrino (1954) and by Eisfeld and Koch (1954) . Other workers have since utilized starch block (Rosenberg, 1959; Keiding, 1959) , agar gel (Stevenson, 1961) , cellulose acetate (Korner, 1962) , starch gel (Estbom, 1959) , and polyacrylamide gel (Allen and Hyncik, 1963) .
However, although the intestinal isoenzyme could be separated from the liver or bone isoenzymes by such techniques, the latter two could not be differentiated from one another. Further, starch gel electrophoresis, the most popular of these techniques, usually separates each tissue alkaline phosphatase into two or more isoenzymes, so that when there is more than one tissue of origin, interpretation becomes difficult.
In this laboratory, a very rapid and relatively simple technique of agar gel electrophoresis has been developed in conjunction with a superior visualization technique to enable liver, bone, intestinal, and other types of alkaline phosphatase to be clearly separated. When used in conjunction with L-phenylalanine inhibition and heat stability, the tissues of origin can be reliably made on every specimen studied.
Studies on nearly 2,000 sera have shown that serum alkaline phosphatase originates from several organs. In infants and children, two isoenzymes are found. One appears to be derived from the liver and the other from bone. The activity of the bone isoenzyme appears to be highest at birth and declines with age. This is not surprising in view of the close relationship of total serum alkaline phosphatase activity in children to the measured rate of bone growth (Clark and Beck, 1950) .
In adult life there is no bone isoenzyme detected in the serum by the technique used. The liver type isoenzyme is present in the vast majority of people. Prolonged incubation with the substrate produced an intestinal isoenzyme in three of 10 sera. It is interesting to compare this with the result reported by other workers using starch gel electrophoresis and rather long incubation times. Arfors and his associates (Arfors, Beckman, and Lundin, 1963a, 1963b) have found 28 % having a second slow moving isoenzyme. Beckman (1964) found it in nearly 32% of donors of blood group 0 and B but none in blood group A.
Later studies (Bamford, Harris, Luffman, Robson, and Cleghorn, 1965; Hope, 1966) have found it in between 16-1 and 69-2%, depending on the blood group. Thus, it appears that as longer incubation times are used, the small amount of intestinal phosphatase activity present can be shown up. Significantly, while bone isoenzyme was readily detected in osteoblastic bone disorders in the present study, even prolonged incubation times failed to show it in normal adult sera. It may thus be inferred that the predominant serum alkaline phosphatase is of the liver type, with variable but small amounts of intestinal isoenzyme, and very little, if any, bone isoenzyme.
In pregnancy, the electrophoretic properties and the heat stability of the serum enzyme imply that the increase is of placental origin. These findings confirm those of McMaster, Tennant, Clubb, Neale, and Posen (1964) , who were the first to utilize the heat-stable property of placental alkaline phosphatase to study this problem, and those of Zuckerman and Sadovsky (1965) who used the same technique. The latter have also shown that placental alkaline phosphatase has a greater affinity for ,B-glycerophosphate than p-nitrophene phosphate. During pregnancy, serum alkaline phosphatase shows a progressively increasing preference for /-glycerophosphate while this is not seen in patients with bone or hepatobiliary disorders .
The overall evidence thus leaves little doubt that the increase in serum alkaline phosphatase in pregnancy is of placental origin.
In bone disorders associated with increased osteoblastic activity there is an increase in serum alkaline phosphatase activity (Gutman, 1959) . Such patients show an additional isoenzyme having the electrophoretic mobility characteristic of bone or placental isoenzyme. However, as none of the patients studied were pregnant, and the isoenzyme was found regardless of the sex of the patients, it may be safely concluded that the increase is due to the bone isoenzyme.
In hepatobiliary disorders, there is no detectable bone isoenzyme in the serum but instead the hepatic type of alkaline phosphatase is increased. This suggests that in these disorders the raised serum activity is due to increased output of the enzyme by the liver into the blood stream.
Electrophoresis of bile reveals an isoenzyme having the same electrophoretic mobility as liver type alkaline phosphatase but not bone type. Thus, the widely held theory of impaired excretion of the bone enzyme (Roberts, 1930 (Roberts, , 1933 Armstrong, King, and Harris, 1934; Armstrong and Banting, 1935; Gutman, Olson, Gutman, and Flood, 1940; Gutman, 1959) is not supported by this evidence.
Indeed, other workers have previously found evidence which conflicted with the theory. There is often a dissociation between serum bilirubin and serum alkaline phosphatase in various liver disorders (Burke, 1950) . Metastatic cancer in the liver has long been known to produce hyperphosphatasia without hyperbilirubinaemia (Meranze, Meranze, and Rothman, 1938; Ross, Iber, and Harvey, 1956; Gibbons, 1957) , but the level of alkaline phosphatase does not correlate with the extent of the infiltration.
Similarly a proportion of patients with hepatitis have very high serum alkaline phosphatase levels while a proportion with common bile duct obstruction have appeared normal. Gutman et al. (1940) have drawn attention to the anomaly that infants with biliary atresia usually do not have a serum alkaline phosphatase activity greater than expected Yong for their age. This finding is, however, compatible with the hypothesis that the enzyme originates from the liver. It is known that the livers of infants have a poorer metabolic ability than adult livers, and it is interesting to note that liver type isoenzyme was absent in 30% of the sera of children studied in the present work.
Experiments on animals produce even stronger evidence against the retention theory. Ligation of one hepatic (bile) duct produces gross elevation of serum alkaline phosphatase but little jaundice (Freeman, Chen, and Ivy, 1938; Polin, Spellberg, Teitelman, and Okumura, 1962) . The bile alkaline phosphatase activity was increased, as was the enzyme content of the liver lobe drained by the ligated duct (Polin et al., 1962) . Sebesta, Bradshaw, and Prockop (1964) , using isolated perfused cat livers, found no increase in alkaline phosphatase activity in the perfusate when the bile ducts were patent, but large increases were obtained when these were occluded. This provides strong evidence that the liver is the source of the enzyme. Further, transfusion of high alkaline phosphatase blood from dogs with common bile duct stricture to normal animals resulted in high serum levels for many days, the enzyme activity only declining slowly (Freeman and Chen, 1938; Cantarow and Miller, 1948; Dalgaard, 1951) . Clubb, Neale, and Posen (1965) have infused placental and bone alkaline phosphatase into humans and shown that the half-line in plasma was about seven days. No significant difference was found between subjects with bile duct obstruction and those without. Indeed, the disappearance rate of infused placental alkaline phosphatase from the circulation is similar to that of infused 1311 albumin . This behaviour is to be expected, for the molecular weight of purified alkaline phosphatases from various tissues has been estimated to be between 120,000 and 130,000 (Boyer, 1963) . Indeed, excretion would require a highly specialized transport system for molecules of this size.
Finally one must consider the origin of the hepatic type alkaline phosphatase found in normal adult sera in the present study.
Identical isoenzyme patterns are found with alkaline phosphatase from the endothelium, lung, and choroid plexus. It is also known that in the liver, endothelial cells of the portal and central veins are richer in this enzyme than bile ducts or liver parenchymal cells (Morrison, Karl, Schwartz, and Shank, 1965) . It is therefore probable that liver alkaline phosphatase is derived from the endothelial cells, and the enzyme is indistinguishable from other blood vessel endothelial alkaline phosphatase.
There is probably a second type of alkaline phosphatase found in the biliary system. This enzyme cannot be separated from the other liver type alkaline phosphatase by the agar gel electrophoresis technique, but differences have been shown by Pope and Cooperband (1966) using starch gel electrophoresis.
Raised serum alkaline phosphatase levels in hepatobiliary disease thus would arise by increased liver synthesis of either enzyme: in conditions in which bile duct pressure is increasing the amount of bile type enzyme produced is increased, some of which finds its way into the blood plasma, while in hepatocellular disorders, such as certain cases of cirrhosis and hepatitis, or in metastatic liver disease, there is an increase in the blood vessel type of enzyme produced. In infantile livers this ability to synthesize either enzyme is rudimentary, so that bile duct atresia hardly promotes any increase in alkaline phosphatase.
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